Details

Autor(en) / Beteiligte

• Verrier, Richard L., PhD
• Klingenheben, Thomas, MD
• Malik, Marek, PhD, MD
• El-Sherif, Nabil, MD
• Exner, Derek V., MD, MPH
• Hohnloser, Stefan H., MD
• Ikeda, Takanori, MD
• Martínez, Juan Pablo, PhD
• Narayan, Sanjiv M., MD, PhD
• Nieminen, Tuomo, MD, PhD
• Rosenbaum, David S., MD

Titel

Microvolt T-Wave Alternans Testing Has a Role in Arrhythmia Risk Stratification

Ist Teil von

• Journal of the American College of Cardiology, 2012-04, Vol.59 (17), p.1572-1573

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2012

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Specifically, in the MASTER (Microvolt T-Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial and TWA substudy of SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial), TWA did not predict appropriate implantable cardioverter-defibrillator (ICD) therapy, sudden cardiac death, and/or ventricular tachycardia/fibrillation. [...]even without dedicated trials on therapy guidance, a sizeable number of prospective studies support TWA's utility in risk stratification for life-threatening arrhythmias and its potential value in clinical judgment.